Dividends & Decline: Two Stocks for the Decade

Investing in companies that distribute a portion of their earnings—dividends, they are called—offers a slight refinement to this rather crude calculation. These payouts, reinvested, have historically outperformed their more austere counterparts. Let us consider, then, two such concerns, Bristol Myers Squibb and Amgen, and examine their prospects for survival—and, if fortune smiles, modest prosperity—over the coming decade.








